Iran's Cov-Pars vaccine enjoys 96-years of Razi institute experience
https://parstoday.ir/en/news/iran-i134094-iran's_cov_pars_vaccine_enjoys_96_years_of_razi_institute_experience
The head of Razi Vaccine and Serum Research Institute says the Razi Cov-Pars vaccine will be an excellent option as it is the first injectable-inhaled COVID-19 vaccine of recombinant protein.
(last modified 2021-04-13T02:52:40+00:00 )
Feb 09, 2021 04:53 UTC

The head of Razi Vaccine and Serum Research Institute says the Razi Cov-Pars vaccine will be an excellent option as it is the first injectable-inhaled COVID-19 vaccine of recombinant protein.

MG